The key themes that defined the year behind us will also shape the one ahead. The most-read articles of 2025 tracked a return ...
Safari Martins may be Kenya’s most famous barber. Known as Chief Safro on social media, where he has millions of followers ...
Arch Manning threw for more than 150 yards and rushed for 150 yards, scoring the decisive touchdowns in the fourth quarter of ...
Google updated its JavaScript SEO docs with new guidance on canonical URLs for JavaScript-rendered pages. Keep canonicals ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
However, Recursion’s earnings per share (EPS) fell short, posting an actual EPS of -$0.41 against the forecasted -$0.35, resulting in a 17.14% negative surprise. Additionally, Recursion ...
Recursion Pharmaceuticals (RXRX) saw a sharp uptick in trading as investors looked ahead to the CEO's upcoming presentation at a major AI conference. The focus is on how the company’s AI strategy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results